Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$1.27B |
| 2 |
Alphabet (Google) Class C
GOOG
|
$570M |
| 3 |
Chipotle Mexican Grill
CMG
|
$298M |
| 4 |
Oneok
OKE
|
$279M |
| 5 |
Ameren
AEE
|
$252M |
Top Sells
| 1 |
Apple
AAPL
|
$418M |
| 2 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
$407M |
| 3 |
Atlassian
TEAM
|
$364M |
| 4 |
United Parcel Service
UPS
|
$342M |
| 5 |
Advanced Micro Devices
AMD
|
$295M |
Sector Composition
| 1 | Technology | 31.61% |
| 2 | Healthcare | 19.69% |
| 3 | Financials | 10.19% |
| 4 | Industrials | 9.75% |
| 5 | Consumer Discretionary | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
SES AI
SES
$395M
| $109K | ﹤0.01% |
47,880
+46
| +0.1% | +$105 |
|
2502
EVgo
EVGO
$529M
| $108K | ﹤0.01% |
31,765
+163
| +0.5% | +$552 |
|
2503
Vanda Pharmaceuticals
VNDA
$272M
| $107K | ﹤0.01% |
24,887
+5
| +0% | +$22 |
|
2504
American Well
AMWL
$113M
| $107K | ﹤0.01% |
4,583
| – | – |
|
2505
Trinseo
TSE
$88.1M
| $105K | ﹤0.01% |
12,877
| – | – |
|
2506
SIGA Technologies
SIGA
$603M
| $104K | ﹤0.01% |
19,820
-1
| -0% | -$5 |
|
2507
Lindblad Expeditions
LIND
$803M
| $103K | ﹤0.01% |
14,380
+10
| +0.1% | +$72 |
|
2508
Axogen
AXGN
$735M
| $103K | ﹤0.01% |
20,561
+5
| +0% | +$25 |
|
2509
Nurix Therapeutics
NRIX
$758M
| $102K | ﹤0.01% |
12,933
+10
| +0.1% | +$79 |
|
2510
Dyne Therapeutics
DYN
$2.02B
| $102K | ﹤0.01% |
11,364
+14
| +0.1% | +$125 |
|
2511
Scholar Rock
SRRK
$3.02B
| $101K | ﹤0.01% |
14,284
+25
| +0.2% | +$178 |
|
2512
Lyell Immunopharma
LYEL
$233M
| $101K | ﹤0.01% |
3,461
| – | – |
|
2513
ImmunityBio
IBRX
$2.27B
| $101K | ﹤0.01% |
60,516
+34
| +0.1% | +$57 |
|
|
SHCR
2514
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $101K | ﹤0.01% |
106,399
-214
| -0.2% | -$202 |
|
2515
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $99.2K | ﹤0.01% |
26,478
+86
| +0.3% | +$322 |
|
2516
Ribbon Communications
RBBN
$707M
| $97.5K | ﹤0.01% |
36,457
+8
| +0% | +$21 |
|
2517
MaxCyte
MXCT
$150M
| $95.4K | ﹤0.01% |
30,628
+4
| +0% | +$12 |
|
2518
Funko
FNKO
$179M
| $95K | ﹤0.01% |
12,429
+6
| +0% | +$46 |
|
2519
Solid Power
SLDP
$760M
| $93.5K | ﹤0.01% |
46,409
| – | – |
|
|
QVCGA
2520
QVC Group, Inc. Series A Common Stock
QVCGA
$73.3M
| $93.1K | ﹤0.01% |
3,080
| – | – |
|
2521
Ranpak Holdings
PACK
$435M
| $91.8K | ﹤0.01% |
16,920
+1
| +0% | +$5 |
|
|
TSVT
2522
DELISTED
2seventy bio
TSVT
| $91K | ﹤0.01% |
23,178
-6
| -0% | -$24 |
|
2523
CI&T Inc
CINT
$700M
| $88K | ﹤0.01% |
13,550
| – | – |
|
2524
Evolution Petroleum
EPM
$174M
| $87.3K | ﹤0.01% |
12,767
-3,431
| -21% | -$23.5K |
|
|
OPI
2525
Office Properties Income Trust
OPI
$16.7M
| $86.8K | ﹤0.01% |
21,184
+2
| +0% | +$8 |
|